Targeting the Insulin-like Growth Factor 1 (IGF1R) and Insulin (IR) Receptor with a Dual IGF1R/IR Inhibitor, OSI-906, to Potentiate mTOR Inhibitor Effects in Exeperimental Models of Hepatocellular Carcinoma (HOC)

被引：0
|
作者：
Pivonello, Claudia [1 ]
Negri, Mariarosaria [1 ]
De Martino, Maria Cristina [1 ]
Napolitano, Maria [2 ]
de Angelis, Cristina [1 ]
Izzo, Francesco [2 ]
Colao, Annamaria [1 ]
Hofland, Leo J. [3 ]
Pivonello, Rosario [1 ]
机构：
[1] Univ Naples Federico II, Naples, Italy
[2] Natl Canc Inst G Pascale Fdn, Naples, Italy
[3] Erasmus MC, Rotterdam, Netherlands
来源：
ENDOCRINE REVIEWS | 2014年 / 35卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT-0320
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Epithelial mesenchymal transition (EMT) and IGF-2 expression as determinants of sensitivity to the dual IGF-1R/IR inhibitor OSI-906 in hepatocellular carcinoma
    Zhao, Hui
    Desai, Vidhi
    Wang, Jian
    Epstein, David
    Miglarese, Mark
    Rizzo, Elizabeth
    CANCER RESEARCH, 2011, 71
  • [22] The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript
    Bohula, EA
    Salisbury, AJ
    Sohail, M
    Playford, MP
    Riedemann, J
    Southern, EM
    Macaulay, VM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (18) : 15991 - 15997
  • [23] Clinical significance of insulin-like growth factor 1 receptor (IGF1R) expression in pancreatic cancer
    Hirakawa, Toshiki
    Yashiro, Masakazu
    Morisaki, Tamami
    Aomatsu, Naoki
    Fukuoka, Tatsunari
    Yoshii, Mami
    Hasegawa, Tsuyoshi
    Matsuoka, Junko
    Nagahara, Hisashi
    Kimura, Kenjiro
    Noda, Eiji
    Amano, Ryosuke
    Kubo, Naoshi
    Tanaka, Hiroaki
    Muguruma, Kazuya
    Yamada, Nobuya
    Maeda, Kiyoshi
    Nakata, Bunzo
    Ohira, Masaichi
    Hirakawa, Kosei
    CANCER RESEARCH, 2012, 72
  • [24] Epithelial-Mesenchymal Transition Predicts Sensitivity to the Dual IGF-1R/IR Inhibitor OSI-906 in Hepatocellular Carcinoma Cell Lines
    Zhao, Hui
    Desai, Vidhi
    Wang, Jian
    Epstein, David M.
    Miglarese, Mark
    Buck, Elizabeth
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (02) : 503 - 513
  • [25] OSI-906 restores the sensitivity of ovarian clear cell carcinoma to cisplatin by targeting the IGF1R/AKT pathway
    Liu, Li
    Liang, Changyan
    Zhuo, Chenya
    Jiang, Huiyun
    Ye, Huixia
    Ruan, Tianyuan
    Song, Jiao
    Jiang, Senwei
    Zhang, Yu
    Li, Xiaomao
    MEDICAL ONCOLOGY, 2022, 39 (02)
  • [26] Pharmacodynamic biomarkers for OSI-906, an insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase inhibitor, in cancer patients with advanced solid tumors
    Gedrich, Richard
    Poondru, Srini
    Stephens, Andrew
    Logan, Tiffany
    Hart, Karen
    Buck, Elizabeth
    Carden, Craig
    Lindsay, Colin
    Kaye, Stanley
    Kim, Edward
    Evans, Jeff
    Puzanov, Igor
    Epstein, David
    Miglarese, Mark
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [27] OSI-906 restores the sensitivity of ovarian clear cell carcinoma to cisplatin by targeting the IGF1R/AKT pathway
    Li Liu
    Changyan Liang
    Chenya Zhuo
    Huiyun Jiang
    Huixia Ye
    Tianyuan Ruan
    Jiao Song
    Senwei Jiang
    Yu Zhang
    Xiaomao Li
    Medical Oncology, 2022, 39
  • [28] The Insulin-Like Growth Factor (IGF) Receptor Type 1 (IGF1R) as an Essential Component of the Signalling Network Regulating Neurogenesis
    Alexander Annenkov
    Molecular Neurobiology, 2009, 40 : 195 - 215
  • [29] The Insulin-Like Growth Factor (IGF) Receptor Type 1 (IGF1R) as an Essential Component of the Signalling Network Regulating Neurogenesis
    Annenkov, Alexander
    MOLECULAR NEUROBIOLOGY, 2009, 40 (03) : 195 - 215
  • [30] Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
    Buck, Elizabeth
    Gokhale, Prafulla C.
    Koujak, Susan
    Brown, Eric
    Eyzaguirre, Alexandra
    Tao, Nianjun
    Rosenfeld-Franklin, Maryland
    Lerner, Lorena
    Chiu, M. Isabel
    Wild, Robert
    Epstein, David
    Pachter, Jonathan A.
    Miglarese, Mark R.
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (10) : 2652 - 2664
12345